Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.63, No.3, p.435-441,2016 |
||
| Title: The prognostic significance of epidermal growth factor receptor expression in patients with anal carcinoma | ||
| Author: I. RICHTER, T. JIRASEK, J. DVORAK, E. CERMAKOVA, J. BARTOS | ||
| Abstract: The aim of the present retrospective study was to evaluate the prognostic significance of epidermal growth factor receptor (EGFR) expression in patients treated with radiotherapy or concomitant chemoradiotherapy for squamous cell anal cancer (SCAC) Patients and methods: A total of 17 patients with SCAC (clinical stages I-III) were studies. All patients were treated with radiotherapy (total dose range 40 – 68 Gy), 13 patients received concomitant chemotherapy (7 patients mitomycin/5-fluorouracil, 5 patients cisplatine/5-fluorouracil, 1 patient cisplatine weekly). EGFR expression in the pretreatment biopsieswas assessed with imunohistochemistry. Patients with EGFR expression had significantly shorter progression free survival (PFS) (p=0.0109; HR 9.38, 95% CI 1.75 – 50.35) and overall survival (OS) (p=0.0351; HR 7.11, 95% CI 1.4 – 36.13) than patients without expression EGFR. The 4-year PFS in patients with increased EGFR expression was only 28.57% (95% CI 17.07 – 62.04%) compared to 87.5% (95% CI 64.58 - 100%) in patients without EGFR expression. The 4-year OS in patients with increased EGFR expression was only 50.0% (95% CI 15.35 – 84.65%) compared to 87.5% (95% CI 64.58 – 100.0%) in patients without EGFR expression. Patients with expression EGFR had significantly shorter PFS and OS compared with patients without EGFR expression. |
||
| Keywords: anal carcinoma, epidermal growth factor receptor, chemoradiotherapy, overall survival, progression free survival | ||
| Published online: 16-May-2016 | ||
| Year: 2016, Volume: 63, Issue: 3 | Page From: 435, Page To: 441 | |
| doi:10.4149/313_150913N485 |
||
|
|
 download file |
|